<p>To provide a novel preventive and/or therapeutic agent for obesity. The preventive and/or therapeutic agent for obesity contains as an active ingredient stanniocalcin. The preventive and/or therapeutic agent of the present invention has an excellent activity of inhibiting the differentiation and maturation of adipocytes, thereby being useful as a drug for preventing and/or treating obesity.</p>
